News | August 22, 2013

Michigan Tech Professor Probes Hypertension, Congestive Heart Failure

Qinghui Chen looks to decipher an elusive component with both diseases


August 22, 2013 — Qinghui Chen, assistant professor in Michigan Tech’s kinesiology and integrative physiology department, wants to get to the bottom of two cardiovascular diseases: hypertension and congestive heart failure.

Hypertension is high blood pressure, which contributes to stroke, heart failure and kidney failure. Congestive heart failure is the weakening and inability of the heart to supply sufficient blood flow to meet the needs of the body.

Both are chronic and dangerous — and common worldwide: up to 10 percent of people over age 65 experience congestive heart failure; up to 25 percent are affected by hypertension.

There is an elusive component with both diseases: they agitate the central nervous system, but it is unknown how. Chen says his goal is to decipher these neural mechanisms.

“We know there’s a neural part of these two diseases,” he said, “but we don’t completely understand what’s going on. There’s a gap in the science.”

Exercise also induces significant changes of neural activity, and Chen addresses the role of exercise in mediating the two diseases. “This is important work,” he said. “If we can identify the mechanism, then we can develop a treatment.”

Chen has gone from the clinician to the scientist. He went to medical school in China, then earned a Ph.D. in cardiovascular physiology in Japan, focusing on figuring out the central nervous mechanism of cardiovascular disease.

He came to Tech in 2010 from the University of Texas in San Antonio. In 2009, he received the Recognition Award for Meritorious Research by the Central Nervous Section of the American Physiological Society.

For more information: www.mtu.edu


Related Content

News | Hypertension

April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over ...

Home April 01, 2024
Home
News | Hypertension

March 18, 2024 — The Smidt Heart Institute at Cedars-Sinai recently became one of four institutions in the U.S. and the ...

Home March 18, 2024
Home
News | Hypertension

February 27, 2024 — Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the ...

Home February 27, 2024
Home
News | Hypertension

February 14, 2024 — The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or ...

Home February 14, 2024
Home
News | Hypertension

January 19, 2024 — Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk ...

Home January 19, 2024
Home
News | Hypertension

December 13, 2023 —Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary ...

Home December 13, 2023
Home
News | Hypertension

December 7, 2023 — Indiana University School of Medicine researchers at the school’s South Bend regional campus, in ...

Home December 07, 2023
Home
News | Hypertension

November 15, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the first ...

Home November 15, 2023
Home
News | Hypertension

September 22, 2023 — For many patients with hypertension--an elevated blood pressure that can lead to stroke or heart ...

Home September 22, 2023
Home
News | Hypertension

September 20, 2023 — Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to ...

Home September 20, 2023
Home
Subscribe Now